Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Replimune Group, Inc. | Director | Stock Option (right to buy) | 25.2K | Apr 1, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
NAMS | NewAmsterdam Pharma Co N.V. | Dec 29, 2023 | 0 | $0 | 3 | Dec 29, 2023 | Director |
REPL | Replimune Group, Inc. | Apr 1, 2023 | 1 | $0 | 4 | Apr 4, 2023 | Director |
REPL | Replimune Group, Inc. | Apr 1, 2022 | 1 | $0 | 4 | Apr 5, 2022 | Director |
FRBN | Forbion European Acquisition Corp. | Dec 9, 2021 | 0 | $0 | 3 | Dec 9, 2021 | Director |